286 related articles for article (PubMed ID: 25486197)
41. Discovery of proqodine A derivatives with antitumor activity targeting NAD(P)H: quinone oxidoreductase 1 and nicotinamide phosphoribosyltransferase.
Song J; Zou G; Zhao Z; Zhu Y; Xue J; Ao L; Sun H; Hao H; Zhang B; Xu X
Chin J Nat Med; 2024 Jan; 22(1):75-88. PubMed ID: 38278561
[TBL] [Abstract][Full Text] [Related]
42. Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD
Ratia KM; Shen Z; Gordon-Blake J; Lee H; Laham MS; Krider IS; Christie N; Ackerman-Berrier M; Penton C; Knowles NG; Musku SR; Fu J; Velma GR; Xiong R; Thatcher GRJ
Biochemistry; 2023 Feb; 62(4):923-933. PubMed ID: 36746631
[TBL] [Abstract][Full Text] [Related]
43. Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model.
Sociali G; Raffaghello L; Magnone M; Zamporlini F; Emionite L; Sturla L; Bianchi G; Vigliarolo T; Nahimana A; Nencioni A; Raffaelli N; Bruzzone S
Oncotarget; 2016 Jan; 7(3):2968-84. PubMed ID: 26658104
[TBL] [Abstract][Full Text] [Related]
44. An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma.
Gujar AD; Le S; Mao DD; Dadey DY; Turski A; Sasaki Y; Aum D; Luo J; Dahiya S; Yuan L; Rich KM; Milbrandt J; Hallahan DE; Yano H; Tran DD; Kim AH
Proc Natl Acad Sci U S A; 2016 Dec; 113(51):E8247-E8256. PubMed ID: 27930300
[TBL] [Abstract][Full Text] [Related]
45. Intracellular cAMP contents regulate NAMPT expression via induction of C/EBPβ in adipocytes.
Mitani T; Watanabe S; Wada K; Fujii H; Nakamura S; Katayama S
Biochem Biophys Res Commun; 2020 Feb; 522(3):770-775. PubMed ID: 31791580
[TBL] [Abstract][Full Text] [Related]
46. Physiological and pathophysiological roles of NAMPT and NAD metabolism.
Garten A; Schuster S; Penke M; Gorski T; de Giorgis T; Kiess W
Nat Rev Endocrinol; 2015 Sep; 11(9):535-46. PubMed ID: 26215259
[TBL] [Abstract][Full Text] [Related]
47. Nicotinamide phosphoribosyltransferase/sirtuin 1 pathway is involved in human immunodeficiency virus type 1 Tat-mediated long terminal repeat transactivation.
Zhang HS; Sang WW; Wang YO; Liu W
J Cell Biochem; 2010 Aug; 110(6):1464-70. PubMed ID: 20506278
[TBL] [Abstract][Full Text] [Related]
48. Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer.
Liu HY; Wang FH; Liang JM; Xiang YY; Liu SH; Zhang SW; Zhu CM; He YL; Zhang CH
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2743-2756. PubMed ID: 35776198
[TBL] [Abstract][Full Text] [Related]
49. The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer.
Gallí M; Van Gool F; Rongvaux A; Andris F; Leo O
Cancer Res; 2010 Jan; 70(1):8-11. PubMed ID: 20028851
[TBL] [Abstract][Full Text] [Related]
50. Tripeptide IRW Upregulates NAMPT Protein Levels in Cells and Obese C57BL/6J Mice.
Bhullar KS; Son M; Kerek E; Cromwell CR; Wingert BM; Wu K; Jovel J; Camacho CJ; Hubbard BP; Wu J
J Agric Food Chem; 2021 Feb; 69(5):1555-1566. PubMed ID: 33522796
[TBL] [Abstract][Full Text] [Related]
51. Increased nicotinamide adenine dinucleotide pool promotes colon cancer progression by suppressing reactive oxygen species level.
Hong SM; Hwang SW; Wang T; Park CW; Ryu YM; Jung JH; Shin JH; Kim SY; Lee JL; Kim CW; Yoon G; Kim KH; Myung SJ; Choi KY
Cancer Sci; 2019 Feb; 110(2):629-638. PubMed ID: 30457689
[TBL] [Abstract][Full Text] [Related]
52. NAMPT pathway is involved in the FOXO3a-mediated regulation of GADD45A expression.
Thakur BK; Lippka Y; Dittrich T; Chandra P; Skokowa J; Welte K
Biochem Biophys Res Commun; 2012 Apr; 420(4):714-20. PubMed ID: 22430142
[TBL] [Abstract][Full Text] [Related]
53. Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer.
Kudo K; Greer YE; Yoshida T; Harrington BS; Korrapati S; Shibuya Y; Henegar L; Kopp JB; Fujii T; Lipkowitz S; Annunziata CM
Cancer Gene Ther; 2024 May; 31(5):721-735. PubMed ID: 38424218
[TBL] [Abstract][Full Text] [Related]
54. NAMPT: A critical driver and therapeutic target for cancer.
Gasparrini M; Audrito V
Int J Biochem Cell Biol; 2022 Apr; 145():106189. PubMed ID: 35219878
[TBL] [Abstract][Full Text] [Related]
55. Nicotinamide Phosphoribosyltransferase-elevated NAD
Zhang Y; Wang Y; Lu S; Zhong R; Liu Z; Zhao Q; Wang C
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):1003-1018. PubMed ID: 36864250
[TBL] [Abstract][Full Text] [Related]
56. Nicotinamide phosphoribosyltransferase and SIRT3 expression are increased in well-differentiated thyroid carcinomas.
Shackelford R; Hirsh S; Henry K; Abdel-Mageed A; Kandil E; Coppola D
Anticancer Res; 2013 Aug; 33(8):3047-52. PubMed ID: 23898059
[TBL] [Abstract][Full Text] [Related]
57. Metabolic Response to NAD Depletion across Cell Lines Is Highly Variable.
Xiao Y; Kwong M; Daemen A; Belvin M; Liang X; Hatzivassiliou G; O'Brien T
PLoS One; 2016; 11(10):e0164166. PubMed ID: 27711204
[TBL] [Abstract][Full Text] [Related]
58. Identification of evolutionary and kinetic drivers of NAD-dependent signaling.
Bockwoldt M; Houry D; Niere M; Gossmann TI; Reinartz I; Schug A; Ziegler M; Heiland I
Proc Natl Acad Sci U S A; 2019 Aug; 116(32):15957-15966. PubMed ID: 31341085
[TBL] [Abstract][Full Text] [Related]
59. Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells.
Hesari Z; Nourbakhsh M; Hosseinkhani S; Abdolvahabi Z; Alipour M; Tavakoli-Yaraki M; Ghorbanhosseini SS; Yousefi Z; Jafarzadeh M; Yarahmadi S
Gene; 2018 Oct; 673():149-158. PubMed ID: 29886033
[TBL] [Abstract][Full Text] [Related]
60. The NAMPT/E2F2/SIRT1 axis promotes proliferation and inhibits p53-dependent apoptosis in human melanoma cells.
Zhao H; Tang W; Chen X; Wang S; Wang X; Xu H; Li L
Biochem Biophys Res Commun; 2017 Nov; 493(1):77-84. PubMed ID: 28919418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
